Revvity Inc

RVTY remains in a Stage 2 advancing regime, with price pulling back into dynamic support at the rising 9 and 20 EMAs after distribution at highs. With no mean-reversion eligibility and medium-term bullish bias intact, the pullback into this confluence offers a favorable buying opportunity. Timing is supported by price holding EMAs and no evident exhaustion. The recommended posture is to Buy Now at EMA support.

• ↑3% organic growth in Q1 2026, led by diagnostics rebound and AI software
• ↑40% ARR increase YoY highlights robust software segment demand
• ↓China DRG policy changes threaten ~6% of total revenue